Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease
- 3 August 2007
- journal article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 136 (7) , 943-952
- https://doi.org/10.1017/s0950268807008552
Abstract
Over 50% of the global burden of tuberculosis occurs in South East Asia and the Western Pacific. Since 1950, notification rates in high-income countries in these settings have declined slowly and have remained over ten-fold greater than those in Western populations. The reasons for the slow decline are poorly understood. Using an age-structured model describing the incidence of Mycobacterium tuberculosis infection and disease applied to notification data from Hong Kong, we illustrate that in Hong Kong, a high prevalence of M. tuberculosis infection among older individuals and a high risk of disease through reactivation (e.g. up to 17-fold greater than that estimated for infected males in the United Kingdom) may explain this slow decline. If this feature of the epidemiology of tuberculosis is widespread, the WHO directly observed treatment short-course (DOTS) strategy may have a smaller impact in Asia in the short term than has been implied by recent predictions, all of which have been based on disease risk estimates derived from Western Europe. As a result, it may be difficult to meet the targets for tuberculosis control, which have been prescribed by the UN Millennium Development Goals.Keywords
This publication has 22 references indexed in Scilit:
- Tuberculosis epidemiology in six provinces of Vietnam after the introduction of the DOTS strategy.2006
- Smoking and tuberculosis in Hong Kong.2003
- Molecular and Conventional Epidemiology of Tuberculosis in Hong Kong: a Population-Based Prospective StudyJournal of Clinical Microbiology, 2003
- The Singapore Tuberculosis Elimination Programme: the first five years.2003
- Prospects for worldwide tuberculosis control under the WHO DOTS strategyThe Lancet, 1998
- Long-term Trends in TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in MalawiThe Lancet, 1996
- Effects of strong government measures against tobacco in Hong Kong.BMJ, 1986
- The development of clinical tuberculosis following infection with tubercle bacilliTubercle, 1982
- Tuberculosis in Hong KongTubercle, 1963